These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1685826)

  • 1. Soluble IL2 receptor serum levels and epidermal cytokines in mycosis fungoides and related disorders.
    Zachariae C; Larsen CS; Kaltoft K; Deleuran B; Larsen CG; Thestrup-Pedersen K
    Acta Derm Venereol; 1991; 71(6):465-70. PubMed ID: 1685826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
    Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 13-cis-retinoic acid effective in mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group.
    Thomsen K; Molin L; Volden G; Lange Wantzin G; Hellbe L
    Acta Derm Venereol; 1984; 64(6):563-6. PubMed ID: 6084938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients.
    Przybilla B; Burg G; Schmoeckel C; Braun-Falco O
    Acta Derm Venereol; 1983; 63(6):524-9. PubMed ID: 6198843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].
    Meissner K; Löning T; Rehpenning W
    Hautarzt; 1991 Feb; 42(2):84-91. PubMed ID: 2037492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ultrastructure of mycosis fungoides, of Sezary's syndrome, and of Woringer-Kolopp's disease (pagetoid reticulosis).
    Braune-Falco O; Schmoeckel C; Wolff HH
    Bull Cancer; 1977; 64(2):191-208. PubMed ID: 143973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of parapsoriasis en plaques, mycosis fungoides, and Sézary's syndrome with trioxsalen baths followed by ultraviolet light.
    Fischer T; Skogh M
    Acta Derm Venereol; 1979; 59(2):171-3. PubMed ID: 84498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer factor therapy in mycosis fungoides: a double-blind study.
    Thestrup-Pedersen K; Grunnet E; Zachariae H
    Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
    Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
    Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemotherapy for mycosis fungoides: a clinical and histological study.
    Lowe NJ; Cripps DJ; Dufton PA; Vickers CF
    Arch Dermatol; 1979 Jan; 115(1):50-3. PubMed ID: 760657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides.
    Cen P; Duvic M; Cohen PR; Kurzrock R
    J Am Acad Dermatol; 2008 Mar; 58(3):382-6. PubMed ID: 18280334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis fungoides--a review of the management of 28 patients and of the recent literature.
    Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S
    Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformed mycosis fungoides: clinicopathological features and outcome.
    Barberio E; Thomas L; Skowron F; Balme B; Dalle S
    Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nature of mycosis fungoides.
    Lawrence CM; Marks JM; Burridge A; Moss C; Ive FA; McGibbon D; Parker S; Coburn P; Shuster S
    Q J Med; 1986 Mar; 58(227):281-93. PubMed ID: 3737871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
    Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.